Thermobalancing therapy as the first-line treatment enables effective and safe chronic disease management at home and can reduce Healthcare costs Internationally

Thermobalancing therapy as the first-line treatment enables effective and safe chronic disease management at home and can reduce Healthcare costs Internationally

Joint Event on Healthcare and Health Management & Cardiology and Cardiac Surgery
August 27-28, 2018 | London, UK

Simon Allen

Fine Treatment, UK

Scientific Tracks Abstracts : J Public Health Policy Plann

Abstract:

Objective: Elderly people usually live with one or more chronic diseases. A person after 67 without a chronic illness has a chance to live 22 years longer than people with a chronic condition. Thermobalancing therapy (TT) with Dr Allen’s therapeutic Devices (DATD) provide effective care for various chronic diseases, therefore, they are important tools to extend the healthy life of people.

Methods: The use of TT and DATD has been studied in adults with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), kidney stone disease and benign prostatic hyperplasia (BPH). The empirical evidence has been gathered for about 10 years in people with these chronic non-malignant conditions. Two clinical trials observed the dynamics of clinical characteristics and parameters, such as symptoms, quality of life (QoL) and ultrasound prostate volume (PV) before and after use of TT with DATD. These results were compared with men in the notreatment control groups. 124 men with BPH and 45 men with

CP/CPPS used DATD for 6-month period, as mono-therapy. Results: Empirical data 4 people with kidney stone disease who were selected from the total number of observations for 10 years showed that after using DATD, the kidney stones were dissolved without side effects. The outcomes of clinical trials confirmed TT with DATD has diminished PV in men with CP/ CPPS from 45mL to 31mL and in men BPH from 31mL to 27mL; symptoms and QoL improved significantly in both treatment groups, while in the control groups there were no positive changes.

Conclusions: Kidney stone disease, CP/CPPS and BPH are common problems affecting 30% of population. Management of chronic non-malignant prostate and kidney diseases using TT with DATD creates an opportunity for people with such conditions to remain healthier with aging. TT enables effective and safe chronic disease management at home and can reduce healthcare costs internationally.

Biography:

Simon Allen is a highly experienced medical professional, with over 45 years of work experience in clinical medicine. He obtained a PhD in Medicine in 1978. For over 14 years, he worked at and subsequently headed a hospital’s cardio-vascular department, and treated patients with renal diseases. At the age of 33 he had authored more than 50 scientific articles on metabolic disorders, including those linked to obesity, kidneys, arthritis, cardio-vascular and gastroenterological diseases. He lectured medical doctors pursuing higher medical qualifications. He then devoted nearly two decades to further medical research into various chronic diseases. He is the author of The Origin of Diseases Theory and the inventor of the effective devices which enable the Thermobalancing therapy. He is a member of the ATA.

E-mail: finetreatment@gmail.com

PDF HTML